WallStreetZenWallStreetZen

NASDAQ: XENE
Xenon Pharmaceuticals Inc Stock Ownership - Who owns Xenon Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xenon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gary PatouDirector2026-06-051,322$53.14
$70.25kSell
Gillian CannonDirector2026-06-051,190$53.14
$63.24kSell
Dawn SvoronosDirector2026-06-011,416$53.41
$75.63kSell
Steven GannonDirector2026-06-011,416$53.41
$75.63kSell
Steven GannonDirector2026-05-123,500$7.38
$25.83kBuy
Andrea DifabioChief Legal Officer2026-03-131,342$55.23
$74.11kSell
Ian MortimerPRESIDENT CEO2026-03-137,308$55.23
$403.58kSell
Christopher John KenneyChief Medical Officer2026-03-131,410$55.23
$77.87kSell
Andrea DifabioChief Legal Officer2026-03-102,607$60.11
$156.70kSell
Christopher John KenneyChief Medical Officer2026-03-102,771$60.11
$166.56kSell

1 of 4

XENE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XENE insiders and whales buy or sell their stock.

XENE Shareholders

What type of owners hold Xenon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC11.19%10,818,491$592.75MInstitution
Avoro Capital Advisors LLC5.98%5,777,777$316.56MInstitution
Blackrock Inc5.83%5,640,118$309.02MInstitution
Wellington Management Group LLP5.00%4,829,641$264.62MInstitution
Driehaus Capital Management LLC4.65%4,491,653$246.10MInstitution
Polar Capital Holdings PLC4.56%4,405,312$241.37MInstitution
Janus Henderson Group PLC4.32%4,175,982$228.80MInstitution
Capital International Investors2.77%2,674,727$146.55MInstitution
Citadel Advisors LLC2.74%2,652,990$145.36MInstitution
Jpmorgan Chase Co1.99%1,923,610$105.39MInstitution

1 of 3

XENE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XENE97.56%2.44%Net SellingNet Selling
CRSP69.13%30.87%Net BuyingNet Selling
TVTX63.57%36.43%Net SellingNet Selling
LEGN25.86%0.15%Net SellingNet Selling
ORKA25.55%74.45%Net BuyingNet Selling
View Top Biotech Stocks

Xenon Pharmaceuticals Stock Ownership FAQ

Who owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals (NASDAQ: XENE) is owned by 103.68% institutional shareholders, 2.60% Xenon Pharmaceuticals insiders, and 0.00% retail investors. Fmr LLC is the largest individual Xenon Pharmaceuticals shareholder, owning 10.82M shares representing 11.19% of the company. Fmr LLC's Xenon Pharmaceuticals shares are currently valued at $590.80M.

If you're new to stock investing, here's how to buy Xenon Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.